{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T14:05:35Z","timestamp":1744121135242},"reference-count":7,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.2169\/internalmedicine.5813-20","type":"journal-article","created":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T22:12:08Z","timestamp":1613340728000},"page":"1115-1117","source":"Crossref","is-referenced-by-count":3,"title":["Drug Fever Due to Favipiravir Administration for the Treatment of a COVID-19 Patient"],"prefix":"10.2169","volume":"60","author":[{"given":"Junsuke","family":"Tawara","sequence":"first","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Uehara","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Sakao","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Igari","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshibumi","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Kasai","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Takayanagi","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misuzu","family":"Yahaba","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomi","family":"Ikusaka","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Chiba University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL. Favipiravir (T-705), a novel viral RNA polymerase inhibitor. Antiviral Res 100: 446-454, 2013.","DOI":"10.1016\/j.antiviral.2013.09.015"},{"key":"2","unstructured":"2. Cai Q, Yang M, Liu D, et al. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering (Beijing) 6: 1192-1198, 2020."},{"key":"3","unstructured":"3. Chen C, Zhang Y, Huang J, et al. Favipiravir versus Arbidol for COVID-19: a randomized clinical trial. medRxiv. Forthcoming."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dong L, Hu S, Gao J. Discovering drugs to treat coronavirus disease 2019 (COVID-19). Drug Discov Ther 14: 58-60, 2020.","DOI":"10.5582\/ddt.2020.01012"},{"key":"5","unstructured":"5. Takoi H, Togashi Y, Fujimori D, et al. Favipiravir-induced fever in coronavirus disease 2019: a report of two cases. Int J Infect Dis 101: 188-190, 2020."},{"key":"6","unstructured":"6. Doi Y, Kondo M, Ando M, Kuwatsuka Y, Ishihara T; The Japanese Association for Infectious Diseases. Favipiravir observational study interium report 2 [Internet]. 2020 June 26 [cited 2021 Feb 10]. Available from: https:\/\/www.kansensho.or.jp\/uploads\/files\/topics\/2019ncov\/covid19_favip_eng_0928.pdf"},{"key":"7","unstructured":"7. Mackowiak PA, LeMaistre CF. Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the English literature. Ann Intern Med 106: 728-733, 1987."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/7\/60_5813-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T03:56:40Z","timestamp":1617422200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/7\/60_5813-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5813-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}